KPV vs LL-37
Updated 10 sources
Key differences
- 1LL-37 is the antimicrobial. KPV antimicrobial claims rest on work from 2000, and a 2018 study found none for a modified KPV.
- 2LL-37 is antimicrobial and can push inflammation up; KPV is a three-amino-acid anti-inflammatory.
- 3They are often stacked for gut goals.
Side by side
Facts from each record, in the same words as their own pages.
| KPV | LL-37 | |
|---|---|---|
| Category |
|
|
| Evidence |
|
|
| FDA status |
|
|
| WADA |
|
|
| Half-life |
|
|
| Routes |
|
|
| Forms |
|
|
| Reported doses |
|
|
| Most cited frequency |
|
|
| Vial sizes |
|
|
| Mixed vial keeps |
|
|
| Protocols on file |
|
|
Doses shown are what sources report, labelled by origin. Not medical advice.
Read each in full
Sources
10 sources, each checked by date. Record updated Oct 24, 2026. Numbers are restated in our own words and labelled by where they came from.
Regulatory3
- Bulk Drug Substances Nominated for Use in Compounding Under Section 503A (updated April 22, 2026)FDA (Internet Archive copy) · checked Oct 24, 2026
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety RisksFDA · checked Oct 24, 2026
- FDA signals potentially evolving stance toward compounding of certain peptidesGoodwin Procter, via a news report · checked Oct 24, 2026
Competitor guide7
- KPV profilepeptidedeck.com · checked Oct 23, 2026
- LL-37 peptide protocol guidepeptidedosingprotocols.com · checked Oct 24, 2026
- LL-37 profilepeptidesexplorer.com · checked Oct 24, 2026
- KPV dosage chartpeptidedeck.com · checked Oct 23, 2026